Alma system for postpartum bleeding after childbirth
Part of Lungs & breathing, Women’s health & pregnancy clinical trials.
This trial tests a device called Alma to treat heavy bleeding after childbirth when standard medicines and massage haven't worked. It's for women who have lost a moderate amount of blood within 24 hours of delivery, either vaginally or by C-section.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 18 or older
- You are able to understand and agree to join the study
- You have heavy bleeding after childbirth (either vaginal or C-section) within 24 hours of delivery
- You have lost a specific amount of blood (500-1500 ml for vaginal birth, 1000-1500 ml for C-section)
- Your bleeding did not stop after standard first treatments like medicine and uterine massage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special balloon placed in the womb can stop heavy bleeding after childbirth when standard medicines don't work. This could help avoid more serious surgery and keep you safe.
This trial tests two emergency treatments to control heavy bleeding after childbirth when standard medicines haven't worked. One uses a small balloon placed inside the womb, and the other uses a special gauze that helps blood clot.
This study tests a medicine called eptacog alfa to see if it is safe for women in India who have severe bleeding after giving birth. It is for women who did not get better with standard treatments to help the uterus contract.
This study tests a new device called JADA to help stop heavy bleeding after childbirth that doesn't stop with standard medicine and massage. It aims to see if using this device in hospitals can improve outcomes for women with postpartum hemorrhage.
This study looks at a vacuum-based device to help stop severe bleeding after delivery (postpartum hemorrhage), especially when the uterus is not tightening. It may help women who have ongoing bleeding despite standard first medicines to reduce bleeding.
This trial tests a way to predict heavy bleeding after childbirth. It includes people having a vaginal or cesarean delivery and aims to help doctors prepare for and prevent complications.
Hear when a new Postpartum Hemorrhage (Primary) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.